|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/18 | (2006.01) |
| (11) | Number of the document | 3658184 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18755604.8 |
| Date of filing the European patent application | 2018-07-27 | |
| (97) | Date of publication of the European application | 2020-06-03 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
| (46) | Date of publication of the claims translation | 2023-11-27 |
| (86) | Number | PCT/US2018/044071 |
| Date | 2018-07-27 |
| (87) | Number | WO 2019/023564 |
| Date | 2019-01-31 |
| (30) | Number | Date | Country code |
| 201762537741 P | 2017-07-27 | US |
| (72) |
ORTIZ, Stephan , US
GENTILE, Jillian , US
PHILOMINATHAN, Leena , US
ROUTHIER, Eric , US
MASON, Bruce , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Vaisto formos su didelėmis anti-C5 antikūno koncentracijomis |
| HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 8 | 185.00 EUR |
| 2026-07-27 |